PharmaBoardroom

East vs West: Bridging the Access Gap in European Cancer Care

From her vantage point as associate vice president for MSD's Central & Eastern Europe (CEE) cluster, Gabriele Grom outlines the disparity that…

5 Top European Mid-Cap CEOs To Know

Bringing together insights from the heads of some of Europe's most prominent mid-cap pharma firms. The leaders of Ipsen, Genmab, Pierre Fabre, Esteve…

Pharma Advertising on Social Media: In Need of a Regulatory…

Joana Silveira Botelho of Cuatrecasas argues for the need for an EU-wide regulatory update on the advertising of pharmaceutical products online, given…

Jun Bao – President & CEO, Impact Therapeutics, China

Dr Jun Bao, appointed president and CEO of Impact Therapeutics in October 2018, shares his aspirations for Impact to be a leader in synthetic…

Mohsen Shalaby – President, Nerhadou International, Egypt

Dr Mohsen Shalaby, President of Nerhadou, explains how he has built Egypt’s leading mineral supplement and nutraceuticals company from scratch…

David Kim – CEO, Cure Therapeutics & CureCell, South…

Cure Therapeutics is a startup developing gene and cell therapies in Korea. Its founder David Kim explains where his passion for regenerative…

NEW France Pharma Report Out Now!

France is rediscovering its mojo. After a period of relative stagnation, the country’s highly strategic USD 65 billion healthcare and life sciences…

James Jungkue Lee – Founder & CEO, Bridge…

James Jungkue Lee, founder and CEO of Bridge Biotherapeutics, explains his strategy for risk mitigation in running a virtual biotech start-up. He also…